The MCS exhibited improved viability and a gene expression profile associated with aggressive tumor characteristics, including increased expression of genes linked to cell survival and motility, such as COL1A1, MSN, HIF1A, TUBB, and ACTB. This evidence concerns the gene MSN and neoplasm.